知名基金经理官宣：“限购”！

Core Viewpoint - Multiple high-performing funds managed by China Europe Fund have announced purchase limits to ensure stable fund operations and protect the interests of fund shareholders [2][3][10]. Fund Purchase Limits - On August 9, China Europe Fund announced that the China Europe Medical Innovation Fund would limit single-day purchases to 100,000 yuan starting August 11 [4][5]. - The China Europe Digital Economy Fund had already suspended large purchases over 1 million yuan starting August 6 [2][5]. - The China Europe Science and Technology Innovation Fund, managed by Shao Jie, will also suspend large purchases over 1 million yuan from August 11 [7]. Fund Performance - As of the end of Q2, the China Europe Medical Innovation Fund had a scale of 8.114 billion yuan, a nearly 20% increase year-on-year [5]. - The fund achieved a one-year return of 80.12%, ranking in the top 2% of its category as of August 8 [5]. - The China Europe Science and Technology Innovation Fund had a one-year return of 84.33%, also ranking in the top 2% of its category [7]. Market Context - The trend of fund purchase limits has been observed across approximately 50 actively managed equity funds since July, particularly among high-performing products [10][11]. - Industry insiders indicate that the recent wave of purchase limits is aimed at controlling fund size to maintain the effectiveness of investment strategies and protect existing shareholders from potential losses due to market volatility [11].